Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Asbestos–Related Pleuropulmonary Diseases: Benign And Malignant

A. Lazarus, A. Massoumi, J. Hostler, David C. Hostler
Published 2012 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract Asbestos is known for its desirable properties of thermal and heat resistance along with excellent strength and durability. It was widely used in many industries since the late 19th century, until its adverse effects on health were recognized. The occurrence of pleuropulmonary changes from exposure to asbestos often has a latency period of 20 to 30 years. The use of asbestos has been banned, regulated, and minimized in many countries, but in several developing countries, the use of asbestos in industries is still a common practice. In this article, the benign and malignant clinical manifestations of asbestos exposure are discussed.
This paper references
10.1016/S0140-6736(03)14794-0
Mesothelin-family proteins and diagnosis of mesothelioma
B. Robinson (2003)
10.1378/chest.08-2665
Malignant pleural mesothelioma: an update on biomarkers and treatment.
M. Ray (2009)
Phase II study of pemetrexed in combination with carboplatin in patients with MPM
B Castagneto (2008)
Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma.
V. Rusch (1997)
10.1080/10937400490231494
Environmental And Occupational Health Hazards Associated With The Presence Of Asbestos In Brake Linings and Pads (1900 To Present): A “State-of-the-Art” Review
D. Paustenbach (2004)
10.1183/09031936.00094008
Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data
C. Paris (2009)
Short - and long - term effects of the outpatient medical rehabilitation for patients with asbestosis [ in German ]
S Dalichau (2010)
10.1378/CHEST.111.5.1424
Asbestos-related disorders. A realistic perspective.
D. M. Rosenberg (1997)
Landris HRM. A roentgenologic study of the effects of dust inhalation on the lung
HK Pancoast (1917)
10.1164/AJRCCM.160.5.9806135
Effect of asbestos-related pleural fibrosis on excursion of the lower chest wall and diaphragm.
B. Singh (1999)
10.5271/SJWEH.2246
Analysis of asbestos fibers and asbestos bodies in tissue samples from human lung. An international interlaboratory trial.
B. Gylseth (1985)
10.1136/oem.2008.045211
Population-based asbestosis surveillance in British Columbia
W. Gan (2009)
10.3816/CLC.2009.n.005
Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma.
A. Tsao (2009)
10.1136/bmj.321.7257.323
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies
R. Peto (2000)
10.1016/S0140-6736(59)91998-1
Reaction of guineapig spermatozoa with homologous antibody: as demonstrated by fluorescent staining.
J. Baum (1959)
10.1056/nejmoa051185
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.
H. Pass (2005)
10.1289/EHP.94102S5229
Persistence of natural mineral fibers in human lungs: an overview.
A. Churg (1994)
10.1001/JAMA.1985.03350440062032
Lung cancer cell type and asbestos exposure.
A. Churg (1985)
10.1136/pgmj.2008.076307
A review of novel biological tools used in screening for the early detection of lung cancer
R. Ghosal (2009)
10.1126/science.1156995
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Catherine Dostert (2008)
10.1002/(SICI)1097-0274(199711)32:5<445::AID-AJIM3>3.0.CO;2-R
Pleural plaques as risk indicators for malignant pleural mesothelioma: a necropsy-based study.
C. Bianchi (1997)
10.1088/1752-7155/4/1/017104
LC-ESI-MS/MS method for oxidative stress multimarker screening in the exhaled breath condensate of asbestosis/silicosis patients.
K. Syslová (2010)
10.1016/S0022-5223(03)00207-1
Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.
R. Flores (2003)
10.1056/NEJM197804272981703
Normal chest roentgenograms in chronic diffuse infiltrative lung disease.
G. Epler (1978)
US National Institutes of Health
Www
10.1136/oem.54.6.403
Routes of asbestos exposure and the development of mesothelioma in an English region.
D. Howel (1997)
10.1186/1745-6673-3-20
Clinical consequences of asbestos-related diffuse pleural thickening: A review
Susan E. Miles (2008)
10.1378/CHEST.114.3.713
Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
F. Bénard (1998)
10.1539/joh.48.309
24 Years of Pneumoconiosis Mortality Surveillance in Australia
D. Smith (2006)
10.1136/oem.50.6.485
Mortality from lung cancer in asbestos workers 1955.
R. Doll (1955)
10.5271/SJWEH.378
Magnetic resonance appearance of asbestos-related benign and malignant pleural diseases.
P. Boraschi (1999)
10.1378/CHEST.125.2.489
Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
B. Duysinx (2004)
10.1378/CHEST.126.3.966
Clinical correlation of asbestos bodies in BAL fluid.
P. Vathesatogkit (2004)
Asbestos in US Geological Survey. Minerals commodity summary
10.1016/j.hoc.2005.09.004
Gene therapy for malignant pleural mesothelioma.
D. Sterman (1998)
10.1136/thx.2004.037267
Asbestos, asbestosis, and lung cancer: a critical assessment of the epidemiological evidence
P. A. Hessel (2005)
A roentgenologic study of the effects of dust inhalation on the lung
H K Pancoast (1917)
Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors
J. Lawson (2006)
10.1056/NEJMoa0906085
Management of lung nodules detected by volume CT scanning.
R. V. van Klaveren (2009)
10.1016/B978-0-323-44284-8.00021-1
Malignant and Borderline Mesothelial Tumors of the Pleura
M. R. Wick (2011)
10.1016/J.IJROBP.2006.03.012
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
A. Allen (2006)
10.1017/S0025727300064334
Too little, too late? The home office and the asbestos industry regulations, 1931.
P. Bartrip (1998)
Asbestosrelated lung disease
KM O’Reilly (2007)
10.1136/oem.28.1.93
International classification of radiographs of pneumoconioses.
P. Elmes (1971)
10.4161/cam.4.1.11361
What's the place of immunotherapy in malignant mesothelioma treatments?
M. Grégoire (2010)
Characteristics of lung cancer patients with asbestos-related radiological findings.
G. Ak (2008)
Comparison of osteopontin, MPF, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma
J Creaney (2008)
10.1148/RADIOL.2372041887
Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.
H. MacMahon (2005)
10.1164/AJRCCM/142.4.843
Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers.
R. Dodson (1990)
10.1378/CHEST.113.6.1517
Progression of asbestosis predicts lung cancer.
P. Oksa (1998)
10.1148/RADIOGRAPHICS.22.SUPPL_1.G02OC10S167
Asbestos: when the dust settles an imaging review of asbestos-related disease.
H. Roach (2002)
10.1016/S1055-3207(03)00045-0
A review of peritoneal mesothelioma at the Washington Cancer Institute.
P. Sugarbaker (2003)
10.1164/AJRCCM.157.3.9707025
Association of cigarette smoking and asbestos exposure with location and histology of lung cancer.
B. Lee (1998)
10.1016/j.lungcan.2008.04.001
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma.
J. Stebbing (2009)
10.1378/chest.08-1345
American College of Chest Physicians consensus statement on the respiratory health effects of asbestos. Results of a Delphi study.
D. Banks (2009)
10.1089/HUM.1998.9.14-2121
Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.
K. Molnar-Kimber (1998)
10.5271/SJWEH.186
Asbestos, asbestosis, pleural plaques and lung cancer.
G. Hillerdal (1997)
10.1001/JAMA.1982.03320300021016
Prevalence and incidence of benign asbestos pleural effusion in a working population.
G. Epler (1982)
10.1016/J.ATHORACSUR.2007.04.076
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
D. Rice (2007)
10.1136/oem.2008.041525
Performance of chest radiograph and CT scan for lung cancer screening in asbestos-exposed workers
B. Clin (2009)
World Health Organization. Elimination of asbestos-related diseases
Too little, too late? The home office and the asbestos industry regulations
P Bartrip (1931)
10.1038/nrc947
SV40 and human tumours: myth, association or causality?
A. Gazdar (2002)
k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
H. Nelson (1999)
10.1007/s11604-010-0449-6
Preliminary study of positron emission tomography/computed tomography and plasma osteopontin levels in patients with asbestos-related pleural disease
S. Kurata (2010)
10.1165/rcmb.2009-0206TR
Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways.
N. H. Heintz (2010)
10.1378/CHEST.95.6.1304
Asbestos and the lung.
M. M. Dunn (1989)
10.5271/SJWEH.226
Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution.
A. Tossavainen (1997)
10.1378/CHEST.95.4.836
Rounded atelectasis. Clinical experience with 74 patients.
G. Hillerdal (1989)
10.1093/ANNHYG/45.5.341
The interaction of asbestos and smoking in lung cancer.
F. Liddell (2001)
10.5271/SJWEH.567
International expert meeting on new advances in the radiology and screening of asbestos-related diseases.
A. Tossavainen (2000)
10.1164/AJRCCM.157.5.9707141
Mechanisms in the pathogenesis of asbestosis and silicosis.
B. Mossman (1998)
10.1136/thx.2006.068999
Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment
G. Loewen (2007)
10.1136/oem.58.3.145
Relation between exposure to asbestos and smoking jointly and the risk of lung cancer
P. Lee (2001)
10.1016/S0007-0971(66)80017-7
The folded lung.
A. Blesovsky (1966)
10.1016/s0140-6736(00)57496-0
Pulmonary asbestosis.
Van die Redaksie (1963)
10.1378/CHEST.126.4.1318
Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies.
M. Pistolesi (2004)
10.1378/CHEST.07-0347
Preoperative evaluation of the patient with pulmonary disease.
Srinivas R. Bapoje (2007)
10.1080/19338241003776104
Asbestos Is Still With Us: Repeat Call for a Universal Ban
C. Ramazzini (2010)
10.1097/MCP.0b013e328335de61
Parenchymal and airway diseases caused by asbestos
Andreea L Antonescu-Turcu (2010)
Outcomes with a platinum plus a gencitabine or pemetrexed as f irst line therapy for MPM in British Columbia
CW Lee (2009)
Practice Guidelines in Oncology: Malignant Pleural Mesothelioma. Version 2
Prophylactic radiotherapy for pleural puncture sites: the controversy continues
HE Davies (2008)
10.1136/thx.2004.022806
Effects of asbestos and smoking on the levels and rates of change of lung function in a crocidolite exposed cohort in Western Australia
H. Alfonso (2004)
10.1200/JCO.2003.11.136
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
10.1093/AJE/KWI034
Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial.
M. Cullen (2005)
10.1007/s004080000083
Mechanisms of Colchicine Effect in the Treatment of Asbestosis and Idiopathic Pulmonary Fibrosis
D. Addrizzo-Harris (2002)
Asbestosisrelated years of potential life lost before age 65 years-United States
(1968)
[Benign asbestos pleural effusion].
S. Kovač (1985)
10.1016/j.lungcan.2008.09.008
Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia.
C. Lee (2009)
10.1097/00063198-200307000-00004
Benign asbestos pleural diseases.
S. Chapman (2003)
Asbestos-related Lung Disease
K. O’Reilly (2007)
10.1200/JCO.2008.20.3943
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
L. Krug (2009)
10.1510/ICVTS.2005.123430
The MARS trial: mesothelioma and radical surgery.
T. Treasure (2006)
10.1378/CHEST.109.1.120
Longitudinal pattern of reported respiratory symptoms and accelerated ventilatory loss in asbestos-exposed workers.
C. Brodkin (1996)
10.1078/1438-4639-00149
Fibre-years, pulmonary asbestos burden and asbestosis.
M. Fischer (2002)
Disorders of the pleura
R. Mason (2002)
10.1136/OEM.47.12.845
Asbestos: a chronology of its origins and health effects.
M. Huncharek (1990)
Selected occupational risk factors
M. Concha-Barrientos (2004)
10.1016/S1470-2045(08)70206-7
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.
H. Linardou (2008)
10.1080/00313020400010955
After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004.
D. Henderson (2004)
10.1097/00004728-199807000-00017
Evaluation of patients with round atelectasis using 2-[18F]-fluoro-2-deoxy-D-glucose PET.
H. McAdams (1998)
10.1097/MCP.0b013e3282fcea50
Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues
H. E. Davies (2008)
10.1093/ANNONC/MDM501
Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM).
B. Castagneto (2008)
10.1055/S-0029-1215245
Kurz- und langfristige Effekte der Ambulanten Medizinischen Rehabilitation für Patienten mit Asbestose
S. Dalichau (2010)
10.1164/ARRD.1984.130.5.884
Pathogenesis of pleural plaques. Relationship of early cellular response and pathology.
S. Sahn (1984)
10.1136/thx.36.12.896
Benign asbestos pleural effusion: diagnosis and course.
B. Robinson (1981)
10.1002/cncr.22526
Therapeutic radiation for lymphoma
M. J. Teta (2007)
10.1136/oem.60.3.201
Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis
Y. Lee (2003)
10.2214/AJR.150.2.269
Asbestos-related pleural disease and asbestosis: a comparison of CT and chest radiography.
A. Friedman (1988)
10.1001/JAMA.1964.03060270028006
ASBESTOS EXPOSURE AND NEOPLASIA.
I. Selikoff (1964)
10.1136/oem.2009.050120
Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile
D. Loomis (2009)
Metabolic imaging of MPM and FDG-PET
F Bérnard (1998)
10.1002/1097-0142(19831201)52:11<1981::AID-CNCR2820521102>3.0.CO;2-P
Malignant mesothelioma. The eastern cooperative oncology group (ECOG) experience
H. Lerner (1983)
Pathogenesis of shrinking pleuritis with atelectasis--"rounded atelectasis".
L. Dernevik (1987)
10.1164/AJRCCM.162.5.9912012
Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease.
S. Mukherjee (2000)
10.1016/j.ccm.2005.12.003
Pleural fibrosis.
M. Jantz (2006)
10.5271/SJWEH.1490
Lobe of origin of lung cancer among asbestos-exposed patients with or without diffuse interstitial fibrosis.
A. Karjalainen (1993)
10.1136/oem.49.10.732
Survival of asbestos insulation workers with mesothelioma.
J. Ribak (1992)
10.1164/rccm.200310-1436st
Diagnosis and initial management of nonmalignant diseases related to asbestos.
D. Smith (2005)
A fuzzy-classifier using a marker panel for the detection of lung cancers in asbestosis patients.
J. Schneider (2007)
10.1016/J.IJROBP.2005.03.041
Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma.
V. Gupta (2005)
10.2214/AJR.154.3.2106209
CT in differential diagnosis of diffuse pleural disease.
A. Leung (1990)
10.1080/10807030590920060
Asbestos in Developing Countries: Magnitude of Risk and Its Practical Implications
T. Joshi (2004)
10.1136/BMJ.2.5158.1024-F
Ghana Medical Service
C. Clarke (1959)
10.1016/J.LUNGCAN.2005.03.002
Asbestos and mesothelioma: worldwide trends.
L. Kazan-Allen (2005)
10.1016/j.jtcvs.2007.10.054
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
R. Flores (2008)
10.1016/J.ATHORACSUR.2005.06.014
Extended surgical staging for potentially resectable malignant pleural mesothelioma.
D. Rice (2005)
10.1016/S0169-5002(02)00180-0
Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis.
T. Berghmans (2002)
10.1136/oem.51.12.804
Malignant mesothelioma: attributable risk of asbestos exposure.
R. Spirtas (1994)
10.1136/oem.2008.043414
Mortality among British asbestos workers undergoing regular medical examinations (1971–2005)
A.-H. Harding (2009)
Asbestos and mesothelioma: worldwide trends. Lung Cancer. 2005;49(suppl 1):S3–S8
L. Kazan-Allen (2005)
Pulmonary asbestosis. BMJ
WE Cooke (1927)
10.1055/s-0029-1215245
[Short- and long-term effects of the outpatient medical rehabilitation for patients with asbestosis].
S. Dalichau (2010)
10.1097/JTO.0b013e318180477b
Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma
J. Creaney (2008)
10.1007/s11864-008-0071-3
Systemic Treatments for Mesothelioma: Standard and Novel
H. Kindler (2008)
10.1148/RADIOL.2362041363
Pleural disease in silicosis: pleural thickening, effusion, and invagination.
H. Arakawa (2005)
10.1016/j.lungcan.2008.09.016
Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway.
Bing Lam (2009)
10.1001/ARCHINTE.1992.00400140073017
Severity of pulmonary asbestosis as classified by International Labour Organisation profusion of irregular opacities in 8749 asbestos-exposed American workers. Those who never smoked compared with those who ever smoked.
K. Kilburn (1992)
10.1043/1543-2165-134.3.462
Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society.
V. Roggli (2010)
10.1080/10408440903044928
Time trend of mesothelioma incidence in the United States and projection of future cases: An update based on SEER data for 1973 through 2005
B. Price (2009)
10.1111/J.1749-6632.1979.TB18749.X
ASBESTOS EXPOSURE, CIGARETTE SMOKING AND DEATH RATES *
E. Hammond (1979)
10.1016/S0140-6736(51)92344-6
Pneumoconiosis. A histological survey of necropsy material in 1205 cases.
S. R. Gloyne (1951)
10.2307/j.ctt20h6v97.9
of the INTERIOR
L. Donald (1962)
10.1148/radiol.2462070712
Fleischner Society: glossary of terms for thoracic imaging.
D. Hansell (2008)
10.1136/oem.2005.020834
The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone
A. Reid (2005)
10.1164/AJRCCM.153.1.8542134
Asbestos-related bilateral diffuse pleural thickening: natural history of radiographic and lung function abnormalities.
D. Yates (1996)
10.1378/CHEST.105.5.1370
Asbestos-induced pleural fibrosis and impaired exercise physiology.
J. F. Shih (1994)
10.1378/CHEST.125.3.1103
Asbestos and the pleura: a review.
D. Cugell (2004)
10.1289/ehp.1002285
The Case for a Global Ban on Asbestos
J. LaDou (2010)
10.1016/j.cbi.2010.03.047
Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis.
G. Liu (2010)
10.1183/09031936.00073606
Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings
T. Vierikko (2007)
10.1136/oem.2008.039172
Asbestosis mortality in the USA: facts and predictions
V. C. dos Santos Antao (2008)
Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. Chest
M Pistolesi (2004)
GUIDELINES FOR THE USE OF THE ILO INTERNATIONAL CLASSIFICATION OF RADIOGRAPHS OF PNEUMOCONIOSES
K. Westfalen (2002)
10.1016/J.JSS.2011.08.019
Murray and Nadel’s Textbook of Respiratory Medicine
Vanessa Nomellini (2012)
10.1111/J.1440-1673.1994.TB00177.X
Radiotherapy in the treatment of malignant mesothelioma of the pleura, with special reference to its use in palliation.
S. Davis (1994)
10.1289/ehp.9481
Vermiculite, Respiratory Disease, and Asbestos Exposure in Libby, Montana: Update of a Cohort Mortality Study
P. A. Sullivan (2007)
10.1136/thorax.57.2.187-a
Statement on malignant mesothelioma in the UK
M. Robinson (2002)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar